[ASAP] Improving Diversity and Integrity in Funding Agency Peer Review Processes đź”— Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.4c00815 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
